This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 92/10/1065    most recent 01.RES.0000073999.07698.33v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teng, X. Articles by Johns, R. A. Search for Related Content PubMed PubMed Citation Articles by Teng, X. Articles by Johns, R. A. Related Collections Angiogenesis Pulmonary biology and circulation Smooth muscle proliferation and differentiation Pulmonary circulation and disease Mechanism of atherosclerosis/growth factors

(Circulation Research. 2003;92:1065.)
© 2003 American Heart Association, Inc.

Report

FIZZ1/RELM, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties

Xingwu Teng^*, Dechun Li^*, Hunter C. Champion, Roger A. Johns

From the Department of Anesthesiology and Critical Care Medicine (X.T., D.L., R.A.J.), Division of Cardiology, Department of Medicine (H.C.C.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Roger A. Johns, MD, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Blalock 1415, 600 N Wolfe St, Baltimore, MD 21287. E-mail Rajohns{at}jhmi.edu

Abstract

In a mouse chronic hypoxia model of pulmonary hypertension, we discovered a novel hypoxia-inducible gene in lung, FIZZ1/RELM, first through a cDNA array analysis and then confirmed by RT-PCR. Western blot and immunohistochemistry revealed that its expression was induced by hypoxia only in lung. The hypoxia-upregulated gene expression was located in the pulmonary vasculature, bronchial epithelial cells, and type II pneumocytes. ³H-thymidine incorporation demonstrated that the recombinant protein stimulated rat pulmonary microvascular smooth muscle cell (RPSM) proliferation dose-dependently ranging from 3.3x10^-9 to 3.3x10^-8 mol/L. Therefore, we renamed this gene as hypoxia-induced mitogenic factor (HIMF). HIMF strongly activated Akt phosphorylation. The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 (10 µmol/L) inhibited HIMF-activated Akt phosphorylation. It also inhibited HIMF-stimulated RPSM proliferation. Thus, the PI3K/Akt pathway, at least in part, mediates the proliferative effect of HIMF. Further studies showed that HIMF had angiogenic and vasoconstrictive properties. HIMF increased pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II.

Key Words: hypoxia-induced mitogenic factor • proliferation • vasoconstriction • angiogenesis • Akt

This article has been cited by other articles:

				D. J. Angelini, Q. Su, K. Yamaji-Kegan, C. Fan, X. Teng, P. M. Hassoun, S. C. Yang, H. C. Champion, R. M. Tuder, and R. A. Johns Resistin-Like Molecule-{beta} in Scleroderma-Associated Pulmonary Hypertension Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 553 - 561. [Abstract] [Full Text] [PDF]

				R. I. Zuberi, X. N. Ge, S. Jiang, N. S. Bahaie, B. N. Kang, R. M. Hosseinkhani, E. M. Frenzel, M. M. Fuster, J. D. Esko, S. P. Rao, et al. Deficiency of Endothelial Heparan Sulfates Attenuates Allergic Airway Inflammation J. Immunol., September 15, 2009; 183(6): 3971 - 3979. [Abstract] [Full Text] [PDF]

				C. Fan, Q. Su, Y. Li, L. Liang, D. J. Angelini, W. B. Guggino, and R. A. Johns Hypoxia-induced mitogenic factor/FIZZ1 induces intracellular calcium release through the PLC-IP3 pathway Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L263 - L270. [Abstract] [Full Text] [PDF]

				K. Yamaji-Kegan, Q. Su, D. J. Angelini, and R. A. Johns IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions J. Immunol., May 1, 2009; 182(9): 5469 - 5476. [Abstract] [Full Text] [PDF]

				T. Liu, B. Hu, Y. Y. Choi, M. Chung, M. Ullenbruch, H. Yu, J. B. Lowe, and S. H. Phan Notch1 Signaling in FIZZ1 Induction of Myofibroblast Differentiation Am. J. Pathol., May 1, 2009; 174(5): 1745 - 1755. [Abstract] [Full Text] [PDF]

				V. Steenwinckel, J. Louahed, M. M. Lemaire, C. Sommereyns, G. Warnier, A. McKenzie, F. Brombacher, J. Van Snick, and J.-C. Renauld IL-9 Promotes IL-13-Dependent Paneth Cell Hyperplasia and Up-Regulation of Innate Immunity Mediators in Intestinal Mucosa J. Immunol., April 15, 2009; 182(8): 4737 - 4743. [Abstract] [Full Text] [PDF]

				M. G. Nair, Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung J. Exp. Med., April 13, 2009; 206(4): 937 - 952. [Abstract] [Full Text] [PDF]

				D. J. Angelini, Q. Su, K. Yamaji-Kegan, C. Fan, J. T. Skinner, H. C. Champion, M. T. Crow, and R. A. Johns Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM{alpha}) induces the vascular and hemodynamic changes of pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L582 - L593. [Abstract] [Full Text] [PDF]

				M. P. Holt, L. Cheng, and C. Ju Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury J. Leukoc. Biol., December 1, 2008; 84(6): 1410 - 1421. [Abstract] [Full Text] [PDF]

				G. Butrous, H. A. Ghofrani, and F. Grimminger Pulmonary Vascular Disease in the Developing World Circulation, October 21, 2008; 118(17): 1758 - 1766. [Full Text] [PDF]

				K. Pawlowski Uncharacterized/hypothetical proteins in biomedical 'omics' experiments: is novelty being swept under the carpet? Brief Funct Genomic Proteomic, July 19, 2008; (2008) eln033v1. [Abstract] [Full Text] [PDF]

				E. Daley, C. Emson, C. Guignabert, R. de Waal Malefyt, J. Louten, V. P. Kurup, C. Hogaboam, L. Taraseviciene-Stewart, N. F. Voelkel, M. Rabinovitch, et al. Pulmonary arterial remodeling induced by a Th2 immune response J. Exp. Med., February 18, 2008; 205(2): 361 - 372. [Abstract] [Full Text] [PDF]

				Y. Takata, H. Osawa, M. Kurata, M. Kurokawa, J. Yamauchi, M. Ochi, W. Nishida, T. Okura, J. Higaki, and H. Makino Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes Hypertension, February 1, 2008; 51(2): 534 - 539. [Abstract] [Full Text] [PDF]

				D. Li, Q. Kang, and D.-M. Wang Constitutive Coactivator of Peroxisome Proliferator-Activated Receptor (PPAR{gamma}), a Novel Coactivator of PPAR{gamma} that Promotes Adipogenesis Mol. Endocrinol., October 1, 2007; 21(10): 2320 - 2333. [Abstract] [Full Text] [PDF]

				S. D. Swain, S. Han, A. Harmsen, K. Shampeny, and A. G. Harmsen Pulmonary Hypertension Can Be a Sequela of Prior Pneumocystis Pneumonia Am. J. Pathol., September 1, 2007; 171(3): 790 - 799. [Abstract] [Full Text] [PDF]

				R. J. Homer Airway remodeling and RELM-beta Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L303 - L304. [Full Text] [PDF]

				Q. Su, Y. Zhou, and R. A. Johns Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis FASEB J, May 1, 2007; 21(7): 1376 - 1382. [Abstract] [Full Text] [PDF]

				K. Yamaji-Kegan, Q. Su, D. J. Angelini, H. C. Champion, and R. A. Johns Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2 Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1159 - L1168. [Abstract] [Full Text] [PDF]

				Q. Tong, L. Zheng, L. Lin, B. Li, D. Wang, and D. Li Hypoxia-Induced Mitogenic Factor Promotes Vascular Adhesion Molecule-1 Expression via the PI-3K/Akt-NF-{kappa}B Signaling Pathway Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 444 - 456. [Abstract] [Full Text] [PDF]

				M. G. Nair, K. J. Guild, and D. Artis Novel Effector Molecules in Type 2 Inflammation: Lessons Drawn from Helminth Infection and Allergy J. Immunol., August 1, 2006; 177(3): 1393 - 1399. [Full Text] [PDF]

				G. Hassanzadeh Ghassabeh, P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions Blood, July 15, 2006; 108(2): 575 - 583. [Abstract] [Full Text] [PDF]

				Q. Tong, L. Zheng, J. Dodd-o, J. Langer, D. Wang, and D. Li Hypoxia-Induced Mitogenic Factor Modulates Surfactant Protein B and C Expression in Mouse Lung Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 28 - 38. [Abstract] [Full Text] [PDF]

				D. Li, L. G. Fernandez, J. Dodd-o, J. Langer, D. Wang, and V. E. Laubach Upregulation of Hypoxia-Induced Mitogenic Factor in Compensatory Lung Growth after Pneumonectomy Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 185 - 191. [Abstract] [Full Text] [PDF]

				K. F. Wagner, A.-K. Hellberg, S. Balenger, R. Depping, J. Dodd-O, R. A. Johns, and D. Li Hypoxia-Induced Mitogenic Factor Has Antiapoptotic Action and Is Upregulated in the Developing Lung: Coexpression with Hypoxia-Inducible Factor-2{alpha} Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 276 - 282. [Abstract] [Full Text] [PDF]